Symbiota is a Cambridge, MA–based developer of microbial solutions that leverage beneficial microbes residing within plants to enhance plant health and agricultural yields. After two years in stealth, the company has built a substantial platform for microbial product discovery and development. Symbiota reports multiple products have advanced into greenhouse and field trials across crops including corn, soy, wheat, cotton and vegetables. The company is progressing its pipeline from platform to applied trials with those target crops. Symbiota is led by Co‑Founder and President Dr. Geoffrey von Maltzahn and Co‑Founder and Board Member Dr. David Berry. Financially, the company completed a Series A financing to support these development and trial activities.

Total raised

$8M

Funding rounds

1

Latest round

Series A

Latest activity

Nov 2014